Streamlined Y-90 radiation for small liver cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a simpler approach to Y-90 radiation therapy for small liver tumors. It aims to see if a focused radiation segment (segmentectomy) can be done safely and effectively for people with early-stage liver cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a liver cancer diagnosis (HCC) and your doctor thinks Y-90 radiation is a good option
- You do not have a TIPS (special shunt) in your liver
- Your liver and kidney function tests are within certain limits (bilirubin under 3.0, albumin over 2.5, and kidney function above 30)
- You are not pregnant and do not need home oxygen for lung disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two liver-directed treatments—radioactive Yttrium-90 beads (SIRT) and a type of chemo infusion directly into the liver (HAIC)—for people whose liver cancer is advanced enough to need treatment but might still be removable with surgery. The goal is to see which approach can shrink the tumor best before surgery.
This trial tests a treatment called radioembolization for small liver cancers. Radioembolization delivers tiny radioactive beads to the tumor, and the goal is to see if it helps shrink or control the cancer.
This study tests whether a targeted radiation treatment called Y-90 segmentectomy can shrink liver tumors. It is for people with one to three small liver tumors that cannot be removed by surgery or destroyed by heat or cold (ablation).
This study tests a special type of radiation therapy called Y-90 TARE (using radioactive beads delivered directly to liver tumors) to find the safest and most effective dose. It's for people with liver cancer or other liver tumors that cannot be removed by surgery.
This trial tests a treatment called Y-90 radioembolization (SIRT) for people with liver cancer that is too large to be removed surgically. The treatment delivers tiny radioactive beads directly to the tumor through the liver's blood supply, which may shrink the tumor and improve outcomes.
This trial tests combining radiation therapy (radioembolization) with surgery to remove part of the liver for people with a single large liver tumor (over 8 cm) that hasn't spread. The goal is to see if this approach can treat the tumor effectively.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.